Financhill
Back

IO Biotech Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

IOBT
IO Biotech

Last Price:
$1.97
Seasonality Move:
-24.93%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IOBT is experiencing buying pressure, which is a positive indicator for future bullish movement.

IO Biotech Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.56 Buy
20-day SMA: 1.46 Buy
50-day SMA: 1.33 Buy
200-day SMA: 1.06 Buy
8-day EMA: 1.37 Buy
20-day EMA: 0.81 Buy
50-day EMA: 0.39 Buy
200-day EMA: 0.11 Buy

IO Biotech Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 74.94 Buy
Chaikin Money Flow: 435874 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 1.6) Buy
Bollinger Bands (100): (0.89 - 1.39) Buy

IO Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for IO Biotech Stock

Is IO Biotech Stock a Buy?

  • IO Biotech share price is 1.89 while IOBT 8-day simple moving average is 1.56, which is a Buy signal.
  • The stock price of IOBT is 1.89 while IO Biotech 20-day SMA is 1.46, which makes it a Buy.
  • IO Biotech 50-day simple moving average is 1.33 while IOBT share price is 1.89, making it a Buy technically.
  • IOBT stock price is 1.89 and IO Biotech 200-day simple moving average is 1.06, creating a Buy signal.

IOBT Technical Analysis vs Fundamental Analysis

Buy
51
IO Biotech (IOBT) is a Buy

Is IO Biotech a Buy or a Sell?

  • IO Biotech stock is rated a Buy
    The current IO Biotech [IOBT] share price is $1.89. The Score for IOBT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.

IO Biotech Stock Info

Market Cap:
124.5M
Price in USD:
1.89
Share Volume:
435.9K

IO Biotech 52-Week Range

52-Week High:
1.90
52-Week Low:
0.66
Buy
51
IO Biotech (IOBT) is a Buy

IO Biotech Share Price Forecast

  • What is the IO Biotech stock price today?
    The IO Biotech stock price is 1.89 USD today.
  • Will IOBT stock go up or go down?
    IO Biotech> share price is forecast to RISE/FALL based on technical indicators
  • Is IO Biotech overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, IO Biotech is not overvalued.

Is IO Biotech Stock a Buy?

  • IO Biotech share price is 1.89 while IOBT 8-day exponential moving average is 1.37, which is a Buy signal.
  • The stock price of IOBT is 1.89 while IO Biotech 20-day EMA is 0.81, which makes it a Buy.
  • IO Biotech 50-day exponential moving average is 0.39 while IOBT share price is 1.89, making it a Buy technically.
  • IOBT stock price is 1.89 and IO Biotech 200-day simple moving average is 0.11, creating a Buy signal.

Fundamental Analysis of IO Biotech

Is IO Biotech a good investment?

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.16 per share.

Technical Analysis of IO Biotech

Should I short IO Biotech stock?

  • IOBT Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting IO Biotech is a Buy
  • IO Biotech Relative Strength Index (RSI) is 74.94, which suggest IO Biotech is overbought
  • The Bollinger Bands (25) for IO Biotech is (1.32 - 1.6), which suggest IO Biotech is a Buy
  • The Bollinger Bands (100) for IO Biotech is (0.89 - 1.39), which suggest IO Biotech is a Buy

* IO Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.